|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0018823,
umls-concept:C0030705,
umls-concept:C0037747,
umls-concept:C0080309,
umls-concept:C0182537,
umls-concept:C0205088,
umls-concept:C0205131,
umls-concept:C0596545,
umls-concept:C0878544,
umls-concept:C1407029,
umls-concept:C1522565,
umls-concept:C2004454
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2009-8-31
|
|
pubmed:abstractText |
Toxic cardiomyopathies are rare and the most frequent cause are anthracycline compounds. Early acute toxicity can be reversible, but at present the only effective therapy for late end-stage anthracycline cardiomyopathy seems to be a heart transplantation. Currently, this transplantation is contraindicated in cases of cancer, at least during the first 4 or 5 years. Recently, implantable axial pumps have shown good results and are used with increasing frequency as destination therapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1873-2623
|
|
pubmed:author |
pubmed-author:BenitoMM,
pubmed-author:CastelloAA,
pubmed-author:FontanillasCC,
pubmed-author:GonzalezJJ,
pubmed-author:GranadosJJ,
pubmed-author:LópezAA,
pubmed-author:ManitoNN,
pubmed-author:MirallesAA,
pubmed-author:OrtizDD,
pubmed-author:RabasaMM,
pubmed-author:RocaJJ,
pubmed-author:S'bragaFF,
pubmed-author:ToralDD,
pubmed-author:ToscaniLL
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
41
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2237-9
|
|
pubmed:meshHeading |
pubmed-meshheading:19715885-Adult,
pubmed-meshheading:19715885-Anthracyclines,
pubmed-meshheading:19715885-Breast Neoplasms,
pubmed-meshheading:19715885-Cardiomyopathies,
pubmed-meshheading:19715885-Disease Progression,
pubmed-meshheading:19715885-Female,
pubmed-meshheading:19715885-Heart Transplantation,
pubmed-meshheading:19715885-Heart-Assist Devices,
pubmed-meshheading:19715885-Humans,
pubmed-meshheading:19715885-Patient Selection,
pubmed-meshheading:19715885-Prostheses and Implants,
pubmed-meshheading:19715885-Spain,
pubmed-meshheading:19715885-Treatment Outcome
|
|
pubmed:articleTitle |
Recovery of ventricular function with a left ventricular axial pump in a patient with end-stage toxic cardiomyopathy not a candidate for heart transplantation: first experience in Spain.
|
|
pubmed:affiliation |
Department of Cardiac Surgery, Bellvitge University Hospital IDIBELL, Hospitalet de Llobregat, Barcelona, Spain. castellscuch@bellvitgehospital.cat
|
|
pubmed:publicationType |
Journal Article,
Case Reports
|
